Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Stem cells in neurology - current perspectives.
NAD(+) protects against EAE by regulating CD4(+) T-cell differentiation.
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.
Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Accurately diagnosing and comprehensively managing MS.
Epstein-Barr virus and multiple sclerosis: association or causation?
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
Magnetic resonance imaging in neuromyelitis optica.
Mitochondrial complex I gene variations; as a potential genetic risk factor in pathogenesis of multiple sclerosis.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
Innovating openly: researchers and patients turn to crowdsourcing to collaborate on clinical trials, drug discovery, and more.
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
Multiple sclerosis, immunomodulation, and immunizations: Balancing the benefits.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I.

Pages